Propanc Biopharma Inc

Propanc Biopharma Inc a biopharmaceutical company develops cancer treatments for patients with pancreatic ovarian and colorectal cancer in Australia Its lead product is PRP a formulation that is in preclinical phase of development designed to enhance the anticancer effects of multiple enzymes The company has a research collaboration with University of Jaen that undertakes the research activities for POP1 joint drug discovery program and a joint research and drug discovery program with Universities of Jaen and Granada to investigate the changes in genetic and protein expression that occur in cancer cells The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma Inc in April 2017 Propanc Biopharma Inc was incorporated in 2007 and is based in Camberwell Australia